Research / CRS / Fundamental state Inspectable configuration
State dimensions Filing 0000017843-18-000047 General Corporate
Debt relative to revenue 0th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
25.29% · OPTIONAL · VALID
Capex intensity 59th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.26% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.70% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth 85th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
20.03% · CORE · VALID
Inventory pressure 6th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
31.94% · OPTIONAL · VALID
Gross margin 88th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
17.71% · CORE · VALID
Operating margin 82th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
8.67% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.89% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 81th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.82% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 105.09%
Current 25.29%
Delta -79.79% Capex Intensity Increased
Previous 4.40%
Current 6.26%
Delta 1.85% Cash Generation Decreased
Previous 12.83%
Current 9.70%
Delta -3.13% Growth Decreased
Previous 20.82%
Current 20.03%
Delta -0.79% Inventory Pressure Decreased
Previous 128.03%
Current 31.94%
Delta -96.09% Margin Increased
Previous 16.78%
Current 17.71%
Delta 0.94% Profitability Increased
Previous 7.90%
Current 8.67%
Delta 0.77% Sbc Intensity Decreased
Previous 0.82%
Current 0.82%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.